| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/01/2023 | Processa Pharmaceuticals, Inc. | PCSA | Grant | Restricted Stock | 30k | $0.00 | $0 | | 12/31/2022 |
| 12/31/2022 | Processa Pharmaceuticals, Inc. | PCSA | Exercise | Common Stock | 18.2k | $0.00 | $0 | By Thompson Family Trust | 12/31/2022 |
| 08/05/2022 | Processa Pharmaceuticals, Inc. | PCSA | Exercise | Common Stock | 1.2k | $0.00 | $0 | | 08/05/2022 |
| 03/31/2022 | Processa Pharmaceuticals, Inc. | PCSA | Grant | Common Stock | 4.4k | $0.00 | $0 | | 03/31/2022 |
| 01/01/2022 | Processa Pharmaceuticals, Inc. | PCSA | Grant | Restricted Stock | 18.2k | $0.00 | $0 | | 03/15/2022 |
| 08/05/2021 | Processa Pharmaceuticals, Inc. | PCSA | Grant | Common Stock | 1.2k | $0.00 | $0 | | 08/05/2021 |
| 06/29/2018 | ARADIGM CORP | ARDM | Grant | Stock Option (Right to Buy) | 97.3k | $1.45 | $141.1k | | 06/29/2018 |
| 06/01/2017 | ARADIGM CORP | ARDM | Grant | Stock Option (Right to Buy) | 110.5k | $1.39 | $153.6k | | 06/01/2017 |
| 05/22/2012 | SAVIENT PHARMACEUTICALS INC | SVNT | Grant | Common Stock, $.01 par value per share | 49.4k | $0.81 | $40k | | 05/22/2012 |
| 05/22/2012 | SAVIENT PHARMACEUTICALS INC | SVNT | Grant | Option to Purchase Common Stock, $0.01 par value | 69.7k | $0.81 | $56.5k | | 05/22/2012 |
| 05/26/2011 | ARADIGM CORP | ARDM | Grant | Stock Option (right to buy) | 100k | $0.19 | $19k | | 05/26/2011 |
| 05/26/2011 | ARADIGM CORP | ARDM | Grant | Common Stock | 131.6k | $0.00 | $0 | | 05/26/2011 |
| 09/23/2010 | SOLIGENIX, INC. | SNGX | Grant | | 300k | $0.21 | $61.5k | | 09/23/2010 |
| 09/02/2010 | SAVIENT PHARMACEUTICALS INC | SVNT | Exercise | Option to Purchase Common Stock, $0.01 par value | 7.5k | $11.81 | $88.6k | | 09/02/2010 |
| 06/08/2010 | SAVIENT PHARMACEUTICALS INC | SVNT | Grant | Option to Purchase Common Stock, $0.01 par value | 4.8k | $11.38 | $55k | | 06/08/2010 |
| 06/08/2010 | SAVIENT PHARMACEUTICALS INC | SVNT | Grant | Common Stock, $.01 par value per share | 3.5k | $11.38 | $40k | | 06/08/2010 |